PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PSTV)

CUSIP: 72941H509

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
179,252,507
Total 13F shares
389,161
Share change
-289,013
Total reported value
$368,744
Price per share
$0.95
Number of holders
17
Value change
-$387,710
Number of buys
10
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 72941H509?
CUSIP 72941H509 identifies PSTV - PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PSTV) as of Q1 2025

As of 31 Mar 2025, PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PSTV) was held by 17 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 389,161 shares. The largest 10 holders included HRT FINANCIAL LP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GEODE CAPITAL MANAGEMENT, LLC, Virtu Financial LLC, UBS Group AG, VANGUARD GROUP INC, Ground Swell Capital, LLC, TWO SIGMA SECURITIES, LLC, Tower Research Capital LLC (TRC), and BlackRock, Inc.. This page lists 17 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.